5 completed, 2 recruiting, 1 terminated. 4 Phase 3, 3 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Recruiting 1 |
| Not applicable | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Elements: new trials by email Literature Review of Elements trials Research Report on Elements
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Advanced Wireless Augmented Reality-Enhanced Exposure Therapy for Posttraumatic Stress Disorder Traditional Exposure Therapy (ET) Treatment, Stepwise Augmented Reality (AR) Component with Traditional Exposure Treatment for Nonresponders - PTSD, Post Traumatic Stress Disorder | Not applicable | Recruiting | Wayne State University | 40 | 2025-09-01 | 2026-01-29 |
| Peau o le Vasa: Analysis of the Efficacy and Feasibility of the PILI Lifestyle Program (PLP) + Social Determinants of Health (SDOH) Intervention and Adaptation of SDOH Measures Pilot Study Partnership for Improving Lifestyle Intervention (PILI) Lifestyle Program + Social Determinants of Health (SDOH) Component - Weight Loss Trial, Cardiometabolic Syndrome | Not applicable | Completed | University of Hawaii | 242 | 2024-09-01 | 2025-10-27 |
| Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants Diphtheria, tetanus and acellular pertussis (component) combined vaccine (adsorbed), Diphtheria, tetanus and acellular pertussis combined vaccine (adsorbed), Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) vaccine (adsorbed) and Haemophilus influenzae type b conjugate vaccine - Healthy Volunteers | Phase 3 | Recruiting | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 1584 | 2023-12-21 | 2024-04-03 |
| Trauma Resuscitation With Low-Titer Group O Whole Blood or Products LTOWB, Components - Wounds and Injuries, Shock, Hemorrhagic | Phase 3 | Completed | University of Alabama at Birmingham | 1100 | 2023-07-27 | 2026-09-22 |
| Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed), Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed) - Streptococcus Pneumoniae Infections | Phase 3 | Completed | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 1110 | 2021-09-16 | 2025-02-10 |
| Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants Multicomponent Meningococcal B Vaccine, Meningococcal Group B Vaccine MenB, Meningococcal Group B Vaccine (recombinant deoxyribonucleic acid [rDNA], component, adsorbed) - Meningococcal Immunisation, Healthy Volunteers | Phase 1 | Terminated | Sanofi Pasteur, a Sanofi Company | 576 | 2021-03-29 | 2025-10-10 |
| Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine, Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Measles, Mumps, and Rubella Virus Vaccine Live - Healthy Volunteers (Meningococcal Infection) | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 525 | 2018-10-17 | 2023-10-19 |
| BHS5 - Testing the Effectiveness of the Exercise Plus Program Exercise Trainer component of the Exercise Plus Program, Plus component (motivation) of the Exercise Plus Program, Exercise Plus Program (exercise + motivation) - Hip Fracture | Not applicable | Completed | University of Maryland, Baltimore | 240 | 2000-07-01 | 2022-03-22 |
Diabetes Mellitus, Type 2 (1) · Diphtheria (1) · Dyslipidemias (1) · Glucose Intolerance (1) · Hemorrhage (1) · Hip Fractures (1) · Hypertension (1) · Meningococcal Infections (1) · Metabolic Syndrome (1) · Motor Activity (1) · Pneumococcal Infections (1) · Shock (1) · Shock, Hemorrhagic (1) · Stress Disorders, Post-Traumatic (1) · Tetanus (1)
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (2) · Sanofi Pasteur, a Sanofi Company (2) · University of Alabama at Birmingham (1) · University of Hawaii (1) · University of Maryland, Baltimore (1) · Wayne State University (1)
United States (5) · China (2) · Mexico (1) · Puerto Rico (1) · Russia (1)
Jan Jansen, MBBS, PhD (1) · Jay Magaziner, Ph.D., MSHyg (1) · Joseph K Kaholokula, PhD (1) · Lin Du (1) · Lin Du, Doctor (1) · Nia Aitaoto, PhD (1) · Ron Acierno, PhD (1) · Sheri Daniels, PhD (1)
PMID 36070134, PMID 38531812, PMID 40753420, PMID 41489614, PMID 41619951
1UG3HL157401-01A1 (1), 2023 (1), OT2HL158287 (1), R01AG017082 (1), U24HL157310 (1)